Literature DB >> 22147133

Locally advanced colorectal cancer: results of surgical treatment and prognostic factors.

Fábio Guilherme Campos1, Maria Célia Calijuri-Hamra, Antonio Rocco Imperiale, Desidério Roberto Kiss, Sergio Carlos Nahas, Ivan Cecconello.   

Abstract

OBJECTIVES: To evaluate the incidence surgical results and prognostic factors of locally advanced colorectal cancer.
METHODS: Cohort study including 679 colorectal cancer patients treated from 1997 to 2007. Clinical, surgical and histological data were analyzed.
RESULTS: Ninety patients (females 61%; median age 59 years) were treated for locally advanced carcinomas (13.2%), either in the colon (66%) or rectum (34%). Extended resections most commonly involved the small bowel (19.8%), bladder (16.4%), uterus (12.9%) and ovaries (11.2%). Postoperative morbidity and mortality occurred in 23 (25.6%) and 3 (3.3%) patients, respectively. Survival and recurrence analysis among 76 R0 (84.4%) procedures revealed a 60% 5-year survival and 34% local recurrence rates. Survival curves demonstrated reduced rates for rectal location (45% vs 65%), tumor depth (50% for T4 vs 75% for T3), vascular/ lymphatic/perineural invasion (35% vs 80%) and lymph node metastasis (35% vs 80%).
CONCLUSIONS: Locally advanced carcinomas were found in 13.2% of patients. Survival rates were negatively affected by rectal location and adverse histological features. Number of involved organs and neoplastic adhesions did not influenced chances of survival. A radical R0 extended resection was achieved in a high proportion of cases, resulting in a 60% cancer-free survival under acceptable operative risks.

Entities:  

Mesh:

Year:  2011        PMID: 22147133     DOI: 10.1590/s0004-28032011000400010

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  10 in total

1.  Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent.

Authors:  Julia Parrish-Novak; Kelly Byrnes-Blake; Narine Lalayeva; Stefanie Burleson; Janean Fidel; Rhonda Gilmore; Pamela Gayheart-Walsten; Gregory A Bricker; William J Crumb; K S Tarlo; Stacey Hansen; Valorie Wiss; Errol Malta; William S Dernell; James M Olson; Dennis M Miller
Journal:  Int J Toxicol       Date:  2017-03-17       Impact factor: 2.032

2.  Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model.

Authors:  Cristina A Metildi; Sharmeela Kaushal; Cynthia S Snyder; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Res       Date:  2012-09-07       Impact factor: 2.192

3.  Smaller tumor size is associated with poor survival in T4b colon cancer.

Authors:  Ben Huang; Yang Feng; Shao-Bo Mo; San-Jun Cai; Li-Yong Huang
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 4.  Current status and future perspectives of fluorescence-guided surgery for cancer.

Authors:  Jonathan C DeLong; Robert M Hoffman; Michael Bouvet
Journal:  Expert Rev Anticancer Ther       Date:  2015-12-07       Impact factor: 4.512

5.  Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.

Authors:  Cristina A Metildi; Sharmeela Kaushal; George A Luiken; Mark A Talamini; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2013-11-19       Impact factor: 3.454

6.  Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival.

Authors:  Qiong Qin; Lin Yang; Yong-Kun Sun; Jian-Ming Ying; Yan Song; Wen Zhang; Jin-Wan Wang; Ai-Ping Zhou
Journal:  Chronic Dis Transl Med       Date:  2017-03-13

7.  PROGNOSTIC FACTORS FOR LEFT COLECTOMY FOR COLON CANCER: A TEN YEARS EXPERIENCE OF A SINGLE UNIVERSITY INSTITUTION.

Authors:  Sergio Carlos Nahas; Caio Sergio Nahas; Leonardo Alfonso Bustamante-Lopez; Rodrigo Ambar Pinto; Carlos Frederico Sparapan Marques; Fabio Guilherme Campos; Ivan Cecconello
Journal:  Arq Bras Cir Dig       Date:  2017 Apr-Jun

Review 8.  Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.

Authors:  Shyam S Mohapatra; Surinder K Batra; Srinivas Bharadwaj; Michael Bouvet; Bard Cosman; Ajay Goel; Wilma Jogunoori; Michael J Kelley; Lopa Mishra; Bibhuti Mishra; Subhra Mohapatra; Bhaumik Patel; Joseph R Pisegna; Jean-Pierre Raufman; Shuyun Rao; Hemant Roy; Maren Scheuner; Satish Singh; Gitanjali Vidyarthi; Jon White
Journal:  Dig Dis Sci       Date:  2018-03-23       Impact factor: 3.199

9.  Prognostic factors affecting outcomes in multivisceral en bloc resection for colorectal cancer.

Authors:  Caio Sergio Rizkallah Nahas; Sergio Carlos Nahas; Ulysses Ribeiro-Junior; Leonardo Bustamante-Lopez; Carlos Frederico Sparapan Marques; Rodrigo Ambar Pinto; Antonio Rocco Imperiale; Guilherme Cutait Cotti; William Carlos Nahas; Daher Cezar Chade; Dariane Sampaio Piato; Fabio Busnardo; Ivan Cecconello
Journal:  Clinics (Sao Paulo)       Date:  2017-05       Impact factor: 2.365

Review 10.  Precision medicine for gastrointestinal cancer: Recent progress and future perspective.

Authors:  Tasuku Matsuoka; Masakazu Yashiro
Journal:  World J Gastrointest Oncol       Date:  2020-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.